Multiple Assemblies exist for SMTL entry 4zom
RORgamma in complex with inverse agonist 4j.; X-RAY DIFFRACTION 2.27 Å

	SMTL ID 4zom.1 Ligands N-{4-[3-(acetylamino)-1-(propan-2-yl)-1H-pyrazol-5-yl]-2-[(1R,5S)-3-azabicyclo[3.1.0]hex-3-yl]phenyl}-2-chloro-6-fluoro-N-methylbenzamide Polypeptides Nuclear receptor ROR-gamma Oligo-state monomer
	SMTL ID 4zom.2 Ligands N-{4-[3-(acetylamino)-1-(propan-2-yl)-1H-pyrazol-5-yl]-2-[(1R,5S)-3-azabicyclo[3.1.0]hex-3-yl]phenyl}-2-chloro-6-fluoro-N-methylbenzamide Polypeptides Nuclear receptor ROR-gamma Oligo-state monomer
	SMTL ID 4zom.3 Ligands N-{4-[3-(acetylamino)-1-(propan-2-yl)-1H-pyrazol-5-yl]-2-[(1R,5S)-3-azabicyclo[3.1.0]hex-3-yl]phenyl}-2-chloro-6-fluoro-N-methylbenzamide Polypeptides Nuclear receptor ROR-gamma Oligo-state monomer
	SMTL ID 4zom.4 Ligands N-{4-[3-(acetylamino)-1-(propan-2-yl)-1H-pyrazol-5-yl]-2-[(1R,5S)-3-azabicyclo[3.1.0]hex-3-yl]phenyl}-2-chloro-6-fluoro-N-methylbenzamide Polypeptides Nuclear receptor ROR-gamma Oligo-state monomer